(Q36602648)

15 August 2017

1 reference

title

The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas (English)

1 reference

15 August 2017

author name string

Anne Linn Johannessen

series ordinal

1

1 reference

15 August 2017

Sverre Helge Torp

series ordinal

2

1 reference

15 August 2017

publication date

23 September 2006

1 reference

Pathology Oncology Research

15 August 2017

published in

1 reference

15 August 2017

volume

12

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

143-147

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02893360

15 August 2017

exact match

0 references

cites work

MIB-1 labeling index in astrocytic tumors--a clinicopathologic study

1 reference

12 December 2020

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

12 December 2020

MIB-1 proliferation index predicts survival among patients with grade II astrocytoma

1 reference

12 December 2020

Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

1 reference

12 December 2020

Proliferative activity and prognosis of low-grade astrocytomas.

1 reference

12 December 2020

Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1.

1 reference

12 December 2020

Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.

1 reference

12 December 2020

Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-6

1 reference

12 December 2020

Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.

1 reference

12 December 2020

Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.

1 reference

12 December 2020

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67

1 reference

12 December 2020

The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature

1 reference

12 December 2020

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

12 December 2020

Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.

1 reference

12 December 2020

Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.

1 reference

12 December 2020

New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.

1 reference

12 December 2020

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02893360

1 reference

15 August 2017

1 reference